{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Facteurs cord : Questions médicales les plus fréquentes",
"headline": "Facteurs cord : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Facteurs cord : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Facteurs cord"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Toxines bactériennes",
"url": "https://questionsmedicales.fr/mesh/D001427",
"about": {
"@type": "MedicalCondition",
"name": "Toxines bactériennes",
"code": {
"@type": "MedicalCode",
"code": "D001427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.123"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Facteurs cord",
"alternateName": "Cord Factors",
"code": {
"@type": "MedicalCode",
"code": "D003311",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Qian Wu",
"url": "https://questionsmedicales.fr/author/Qian%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Acupuncture and Moxibustion, Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China."
}
},
{
"@type": "Person",
"name": "E Bárbara-Bataller",
"url": "https://questionsmedicales.fr/author/E%20B%C3%A1rbara-Bataller",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain. Electronic address: ebb31604@hotmail.com."
}
},
{
"@type": "Person",
"name": "J L Méndez-Suárez",
"url": "https://questionsmedicales.fr/author/J%20L%20M%C3%A9ndez-Su%C3%A1rez",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
},
{
"@type": "Person",
"name": "C Alemán-Sánchez",
"url": "https://questionsmedicales.fr/author/C%20Alem%C3%A1n-S%C3%A1nchez",
"affiliation": {
"@type": "Organization",
"name": "Unidad de Lesionados Medulares, Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
},
{
"@type": "Person",
"name": "P Peñaloza-Polo",
"url": "https://questionsmedicales.fr/author/P%20Pe%C3%B1aloza-Polo",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Rehabilitación del Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The genotype list string code syntax for exchanging nomenclature-level genotyping results in clinical and research data management and analysis systems.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37403548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/tan.15145"
}
},
{
"@type": "ScholarlyArticle",
"name": "PMTCT Data Management and Reporting during the Transition Phase of Implementing the Rationalised Registers in Amathole District, Eastern Cape Province, South Africa.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36497931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph192315855"
}
},
{
"@type": "ScholarlyArticle",
"name": "EnzymeML: seamless data flow and modeling of enzymatic data.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36759590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41592-022-01763-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enabling data sharing and utilization for African population health data using OHDSI tools with an OMOP-common data model.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37361151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2023.1116682"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health data hubs: an analysis of existing data governance features for research.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37430347",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12961-023-01026-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Toxines bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001427"
},
{
"@type": "ListItem",
"position": 5,
"name": "Facteurs cord",
"item": "https://questionsmedicales.fr/mesh/D003311"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Facteurs cord - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Facteurs cord",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Facteurs cord",
"description": "Comment diagnostiquer une infection par Cord Factors ?\nQuels tests sont utilisés pour détecter les Cord Factors ?\nLes Cord Factors sont-ils visibles sur une radiographie ?\nPeut-on identifier les Cord Factors par PCR ?\nQuels symptômes peuvent indiquer une infection par Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Facteurs cord",
"description": "Quels sont les symptômes d'une infection par Cord Factors ?\nLes Cord Factors provoquent-ils des symptômes immédiats ?\nY a-t-il des symptômes spécifiques aux Cord Factors ?\nComment les symptômes évoluent-ils avec les Cord Factors ?\nLes Cord Factors causent-ils des douleurs thoraciques ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Facteurs cord",
"description": "Comment prévenir une infection par Cord Factors ?\nLa vaccination est-elle efficace contre les Cord Factors ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir l'infection par Cord Factors ?\nLes tests de dépistage sont-ils importants pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Facteurs cord",
"description": "Quel est le traitement standard pour une infection par Cord Factors ?\nLes Cord Factors nécessitent-ils un traitement prolongé ?\nY a-t-il des traitements alternatifs pour les Cord Factors ?\nLes Cord Factors sont-ils résistants aux antibiotiques ?\nComment surveiller l'efficacité du traitement des Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Facteurs cord",
"description": "Quelles complications peuvent survenir avec les Cord Factors ?\nLes Cord Factors peuvent-ils causer des infections systémiques ?\nComment les complications affectent-elles le traitement ?\nLes complications sont-elles fréquentes avec les Cord Factors ?\nQuelles sont les conséquences à long terme des Cord Factors ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Facteurs cord",
"description": "Quels sont les principaux facteurs de risque pour les Cord Factors ?\nLe VIH augmente-t-il le risque d'infection par Cord Factors ?\nLes personnes âgées sont-elles plus à risque ?\nLe voyage dans des zones endommagées augmente-t-il le risque ?\nLe contact avec des personnes infectées est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D003311?mesh_terms=Data+Management&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Cord Factors ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests microbiologiques et des cultures de Mycobacterium."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les Cord Factors ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des tests sérologiques peuvent être utilisés pour détecter les Cord Factors."
}
},
{
"@type": "Question",
"name": "Les Cord Factors sont-ils visibles sur une radiographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les Cord Factors ne sont pas visibles sur une radiographie, mais les effets de l'infection le sont."
}
},
{
"@type": "Question",
"name": "Peut-on identifier les Cord Factors par PCR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour identifier les gènes associés aux Cord Factors."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection par Cord Factors ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux persistante, fièvre, et perte de poids, mais varient selon l'individu."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Cord Factors ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, fièvre, sueurs nocturnes et fatigue, souvent liés à la tuberculose."
}
},
{
"@type": "Question",
"name": "Les Cord Factors provoquent-ils des symptômes immédiats ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes peuvent prendre du temps à apparaître après l'infection initiale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux Cord Factors ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont généralement ceux de la tuberculose, sans spécificité pour les Cord Factors."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec les Cord Factors ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec le temps si l'infection n'est pas traitée."
}
},
{
"@type": "Question",
"name": "Les Cord Factors causent-ils des douleurs thoraciques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs thoraciques peuvent survenir en raison de l'infection pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir une infection par Cord Factors ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la vaccination BCG et des mesures d'hygiène pour éviter la transmission."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre les Cord Factors ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG peut réduire le risque de tuberculose, mais n'est pas toujours efficace."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes infectées sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir l'infection par Cord Factors ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, porter un masque peut réduire le risque de transmission dans les zones à risque."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils importants pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet d'identifier et de traiter les infections rapidement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour une infection par Cord Factors ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme l'isoniazide et la rifampicine."
}
},
{
"@type": "Question",
"name": "Les Cord Factors nécessitent-ils un traitement prolongé ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement peut durer plusieurs mois pour éradiquer complètement l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs pour les Cord Factors ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs existent, mais ils doivent être prescrits par un médecin."
}
},
{
"@type": "Question",
"name": "Les Cord Factors sont-ils résistants aux antibiotiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines souches de Mycobacterium peuvent développer une résistance aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement des Cord Factors ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est surveillée par des tests de culture et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Cord Factors ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, la pleurésie et la dissémination de l'infection."
}
},
{
"@type": "Question",
"name": "Les Cord Factors peuvent-ils causer des infections systémiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection non traitée peut se propager et causer des infections systémiques graves."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent rendre le traitement plus complexe et prolonger la durée de la thérapie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec les Cord Factors ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont possibles, surtout si l'infection n'est pas traitée rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences à long terme des Cord Factors ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conséquences peuvent inclure des lésions pulmonaires permanentes et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les Cord Factors ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent l'immunodépression, le tabagisme et la malnutrition."
}
},
{
"@type": "Question",
"name": "Le VIH augmente-t-il le risque d'infection par Cord Factors ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le VIH affaiblit le système immunitaire, augmentant le risque d'infection tuberculeuse."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le voyage dans des zones endommagées augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence de tuberculose augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le contact avec des personnes infectées est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact étroit avec des personnes infectées augmente le risque de transmission."
}
}
]
}
]
}
The nomenclatures used to describe HLA and killer-cell immunoglobulin-like receptor (KIR) alleles distinguish unique nucleotide and peptide sequences, and patterns of expression, but are insufficient ...
The National Department of Health, in March 2015, launched the implementation of Rationalisation of Register, aimed at reducing the amount of time invested in completing the registers and collecting d...
This study explored the effect of the rollout of Rationalisation of Register on the documentation and reporting of Prevention of Mother-to-Child Transmission (PMTCT) programme data with the existing s...
A mixed-method research approach was used, and three source documents, namely: Tally sheet, Antenatal care (ANC) register, and Tick register used for collecting and reporting PMTCT data, were reviewed...
All selected facilities completed the three source documents. The facilities consolidated their PMTCT data monthly before reporting to the District Health Information System (DHIS). Less than half of ...
PMTCT data management and reporting were challenging during the transitioning phase of implementing the rationalised registers because of different timelines instituted in the facilities and non-avail...
The design of biocatalytic reaction systems is highly complex owing to the dependency of the estimated kinetic parameters on the enzyme, the reaction conditions, and the modeling method. Consequently,...
The COVID-19 pandemic has spurred the use of AI and DS innovations in data collection and aggregation. Extensive data on many aspects of the COVID-19 has been collected and used to optimize public hea...
Digital transformation in healthcare and the growth of health data generation and collection are important challenges for the secondary use of healthcare records in the health research field. Likewise...
To capture the different data governance behind health data hubs across Europe, a survey focused on analysing the feasibility of linking individual-level data between data collections and the generati...
In total, 41 survey responses received until June 2022 were analysed. Stratification methods were performed to cover the different levels of granularity identified in some data hubs' characteristics. ...
The analysis of the responses from health data hub respondents across Europe provided a list of the most frequent aspects, which concluded with a set of specific best practices on data management and ...
Previous research has shown that while missing data are common in bioarchaeological studies, they are seldom handled using statistically rigorous methods. The primary objective of this article is to e...
Missing data were simulated on complete datasets of ordinal (n = 287) and continuous (n = 369) bioarchaeological data. Missing values were imputed using five imputation methods (mean, predictive mean ...
In all instances, listwise deletion was least successful at approximating the original parameters. Imputation of continuous data was more effective than ordinal data. Overall, no one method performed ...
These findings support the use of imputation methods over deletion for handling missing bioarchaeological and paleopathology data, especially when the data are continuous. Whereas deletion methods red...
We investigated the association between various food groups and obesity in Japanese patients with type 2 diabetes....
2070 patients with type 2 diabetes who attended 26 diabetes clinics throughout Japan were analyzed and were divided into obese and non-obese groups. Intakes of food groups determined by a food frequen...
Non-obese patients consumed a larger variety of food groups than obese patients, with the diets of non-obese individuals closer to the traditional Japanese diet characterized by fish, seaweed, and soy...
Food groups and their combinations that were strongly associated with obesity in Japanese patients with type 2 diabetes were identified. Our findings also suggested an inverse association between the ...
The adoption of new technologies in clinical care systems has propitiated the availability of a great amount of valuable data. However, this data is usually heterogeneous, requiring its harmonization ...
The framework includes an ontology-based common data model (i.e. SCDM), a data transformation pipeline and a semantic query system. Heterogeneous datasets, mapped to different terminologies, are integ...
Several datasets from different European institutions have been integrated by using the framework in the context of the European H2020 Precise4Q project. Through the query system, data scientists were...
The flexible data representation using RDF, together with the formal semantic underpinning provided by the SCDM, have enabled the semantic integration, query and advanced exploitation of heterogeneous...
The German initiative "National Research Data Infrastructure for Personal Health Data" (NFDI4Health) focuses on research data management in health research. It aims to foster and develop harmonized in...
Telecommunication (telco) cloud services have emerged as crucial components in the modern digital landscape, offering extensive capabilities for data management, connectivity, and service provision. H...